Elsevier

Sleep Medicine Reviews

Volume 32, April 2017, Pages 58-68
Sleep Medicine Reviews

Clinical review
Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease: A systematic review

https://doi.org/10.1016/j.smrv.2016.02.007Get rights and content

Summary

The objective of this systematic review is to synthesize the evidence on prevalence, polysomnographic findings and clinical outcomes of co-morbid obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) – known as the “overlap syndrome”. We systematically searched PubMed on 1 December 2015 using appropriate medical subject headings (MeSH) and text words to capture prevalence studies and comparative studies of any observational design examining the clinical outcomes in patients with co-existent COPD and OSA. We reviewed 591 articles and included 27 in the final review. In total, 21 observational studies (n = 29,341 participants) provided prevalence estimates. Overlap syndrome is not common in the general and hospital population (range: 1.0–3.6%), but is highly prevalent in patients diagnosed with either obstructive sleep apnea (range: 7.6–55.7%) or COPD (range: 2.9–65.9%). Overlap syndrome patients have been shown to have greater nocturnal oxygen desaturation (NOD) (i.e., reduced mean peripheral capillary oxygen saturation (SpO2) and increased sleep time spent with SpO2 < 90% (T90)) and worse sleep quality than patients with only OSA. It is associated with more frequent cardiovascular morbidity, poorer quality of life (QoL), more frequent COPD exacerbation and increased medical costs. This systematic review on overlap syndrome highlights the limitations and knowledge gaps of its prevalence, etiology and underlying pathophysiologic mechanisms related to increased morbidity and mortality.

Introduction

Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) are common respiratory diseases. The concurrent presence of these two conditions in one individual is referred to as the “overlap syndrome” [1], a term first introduced by D.C. Flenley [2]. COPD is characterized by airflow obstruction, which is not fully reversible [3]. Obstructive sleep apnea results from obstruction of upper airway during sleep and leads to periodic apneas and hypopneas causing reduction in blood oxygen saturation. This often leads to symptoms like loud snoring, awakening due to gasping and choking and daytime sleepiness [4], [5]. There is substantial variation in the reported prevalence estimates for overlap syndrome between epidemiological studies thus far. This is likely to relate to the use of differing definitions for both OSA and COPD, and different study populations. Although narrative reviews exist which have highlighted some of these limitations in the current evidence and outlined gaps in our knowledge [1], [6], the evidence has not been systematically reviewed and synthesized.

The simultaneous occurrence of COPD and OSA can lead to more pronounced nocturnal oxygen desaturation (NOD) than when either condition occurs in isolation, which subsequently may increase the risk of multiple comorbidities ∗[7], ∗[8]. OSA causes repetitive and transient oxygen desaturations that induce oxidative stress, autonomic dysfunction, systemic inflammation and endothelial dysfunction. These have been proposed as possible complex pathophysiological mechanisms for the development of cardiovascular disease among OSA patients [9], [10]. Additionally, COPD increases the risk of cardiovascular disease by increased sympathetic nervous activity and persistent low-grade systematic inflammation [11]. However, whether these effects are additive or synergistic in overlap syndrome patients is not yet established and there is no epidemiological evidence studying the possible interaction between these two disorders on the development of cardiovascular diseases.

COPD patients with co-existent OSA have been reported to have poorer health related quality of life (QoL), in part related to sleep disruption and worse nocturnal oxygen desaturation [12]. The presence of sleep apnea has been shown to increase the rate of COPD exacerbation, hospitalization and mortality when compared with COPD-only patients ∗[13], [14]. Given that co-existing COPD and OSA patients have increased healthcare utilization, this poses a significant economic burden on the health system [15] Therefore, early identification and timely treatment is imperative for reducing morbidity and mortality in patients with overlap syndrome.

To our knowledge, no systematic review to date has collated evidence on the prevalence and clinical outcomes of overlap syndrome. The objective of this systematic review is to synthesize the evidence from observational epidemiological studies and, subsequently, recommend future research directions in this field.

Section snippets

Methods

We conducted this systematic review by following the meta-analysis of observational studies in epidemiology (MOOSE) guidelines [16].

Results

Our final PubMed search yielded 591 articles. We excluded 542 articles after preliminary screening of titles and abstracts against the eligibility criteria. After reviewing full texts of 49 articles, 27 articles were selected for inclusion (Fig. 1). All the studies were conducted on middle aged to elderly populations of participants aged from 40 to 90 y.

Prevalence of overlap syndrome

The included studies reported the prevalence of overlap syndrome in three groups i.e., samples taken from the general and hospital population, OSA patients and COPD patients. The studies that included samples from the general population and hospitals reported much lower prevalence of overlap syndrome than the studies that sampled patients with either OSA or COPD.

Polysomnographic findings in overlap syndrome patients

Eight studies reported the findings from polysomnography of overlap syndrome patients and compared them with OSA only patients ∗[7], [18], ∗[19], [26], [32], [33], ∗[34] (Table 4). There were no significant differences in AHI across the included studies. The oxygen desaturation measured by mean peripheral capillary oxygen saturation (SpO2) was significantly greater in overlap syndrome patients than OSA patients in most of the studies ∗[7], [18], [32], [33]. In overlap patients, total sleep time

Clinical outcomes in overlap syndrome patients

The included studies reported various types of clinical outcomes, including cardiovascular diseases, mortality, COPD exacerbation, quality of life, as well as utilization of medical resources and associated costs (Table 5). Overlap syndrome was associated with increased nocturnal oxygen desaturation leading to increased cardiovascular comorbidities, including significantly higher proportions of pulmonary hypertension ∗[7], [32]; a higher incidence of new-onset atrial fibrillation [21] and right

Discussion

From this systematic review, the major findings are: 1) overlap syndrome is not common in the general population (range 1–3.6%), but is highly prevalent when populations of either COPD or OSA are assessed (range: 2.9–65.9%); 2) overlap syndrome patients suffer from a greater degree of NOD (i.e., reduced mean SpO2 and increased sleep time spent with SpO2 < 90%) and worse sleep quality than patients with OSA alone; 3) compared to either condition alone, overlap syndrome is associated with more

Conclusion

This systematic review documents that even though COPD and OSA are individually quite common in the general population, their co-existence is not highly prevalent at a population level. However, overlap syndrome is much more common when considering populations diagnosed with either OSA or COPD. Unfortunately, current evidence is not sufficient to delineate the true association between these two diseases due to variations in study population, definition, and methodology. The overlap syndrome is

Conflicts of interest

The authors do not have any conflicts of interest to disclose.

Acknowledgments

No financial support was taken for conducting this systematic review. Associate Professor Garun Hamilton has received equipment for research from Resmed, Philips Respironics and Compumedics Ltd. None of the other authors declared a conflict of interest.

References (51)

  • C. Zamarron et al.

    Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences

    Int J Chron Obstruct Pulmon Dis

    (2008)
  • A. Chaouat et al.

    Association of chronic obstructive pulmonary disease and sleep apnea syndrome

    Am J Respir Crit Care Med

    (1995)
  • R.L. Owens et al.

    Sleep-disordered breathing and COPD: the overlap syndrome

    Respir Care

    (2010)
  • D.D. Sin et al.

    Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease

    Can J Physiol Pharmacol

    (2005)
  • C. Mermigkis et al.

    Health-related quality of life in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease (overlap syndrome)

    Int J Clin Pract

    (2007)
  • J.M. Marin et al.

    Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome

    Am J Respir Crit Care Med

    (2010)
  • P. Lavie et al.

    Mortality risk factors in sleep apnoea: a matched case–control study

    J Sleep Res

    (2007)
  • F.T. Shaya et al.

    Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome

    Sleep Breath

    (2009)
  • D.F. Stroup et al.

    Meta-analysis of observational studies in epidemiology: a proposal for reporting

    JAMA

    (2000)
  • G. Wells et al.

    The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses

    (2015)
  • M. Bednarek et al.

    There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study

    Respiration

    (2005)
  • M.H. Sanders et al.

    Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease

    Am J Respir Crit Care Med

    (2003)
  • M. Azuma et al.

    Associations among chronic obstructive pulmonary disease and sleep-disordered breathing in an urban male working population in Japan

    Respiration

    (2014)
  • H.V. Ganga et al.

    Risk of new-onset atrial fibrillation in elderly patients with the overlap syndrome: a retrospective cohort study

    J Geriatr Cardiol

    (2013)
  • M.L. Stanchina et al.

    Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome

    J Clin Sleep Med

    (2013)
  • Cited by (115)

    • Sleep and obstructive lung disease

      2023, Encyclopedia of Sleep and Circadian Rhythms: Volume 1-6, Second Edition
    View all citing articles on Scopus
    1

    Equal senior author.

    The most important references are denoted by an asterisk.

    View full text